Nanologica AB (publ) (STO:NICA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.6460
-0.0480 (-6.92%)
Jan 21, 2026, 5:19 PM CET
-72.39%
Market Cap61.33M
Revenue (ttm)22.65M
Net Income (ttm)-47.51M
Shares Out88.37M
EPS (ttm)-0.56
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume22,491
Average Volume209,932
Open0.6940
Previous Close0.6940
Day's Range0.6160 - 0.6940
52-Week Range0.5860 - 2.5000
Beta-0.07
RSI32.74
Earnings DateFeb 12, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 19
Stock Exchange Nasdaq Stockholm
Ticker Symbol NICA
Full Company Profile

Financial Performance

In 2024, Nanologica AB's revenue was 14.54 million, an increase of 211.17% compared to the previous year's 4.67 million. Losses were -65.63 million, -12.68% less than in 2023.

Financial Statements